A healthy planet is the foundation of our well-being, providing us with clean air, water, and the resources we need. Yet, climate change, pollution, and biodiversity loss are directly impacting our health.
At Chiesi, we are committed to addressing these issues — reducing emissions, conserving resources, and combating climate change — to build a sustainable future in which both the planet and future generations can continue to thrive.
Our path to Net Zero
Chiesi has set an ambitious goal to achieve Net Zero greenhouse gas (GHG) emissions across its entire value chain by 2035.
Reaching this objective requires reducing absolute emissions by at least 90% and limiting reliance on carbon removal to no more than 10% of residual emissions.
Through these efforts, Chiesi is aligning its climate strategy with the Paris Agreement and its ambition to limit global warming to 1.5°C above pre-industrial levels by 2100.
A science-based and transparent approach
To ensure that its Net Zero commitment is scientifically robust and credible:
- Chiesi’s targets have been assessed and approved by the Science Based Targets initiative (SBTi) and cover Scope 1, Scope 2, and Scope 3 emissions.
- Greenhouse gas emissions are measured in line with the GHG Protocol and are subject to annual third-party audit and verification.
- Climate governance, strategy, and risk management are aligned with the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD), and a TCFD report is published annually as part of Chiesi’s ESG reporting.
- Chiesi participates in the Carbon Disclosure Project (CDP) each year and received an “A” rating in 2025.
90%
Absolute reduction of scope 1 and 2 GHG emissions by 2030 from a 2019 base year.
90%
Reduction of Scope 3 GHG emissions from use of sold production, purchased goods and services and business travel by 2035 from a 2019 base year.
Chiesi commits to neutralize residual emissions by 2035.
We’re changing so patients don’t have to
With the goal of providing sustainable respiratory solutions for patients living with asthma and COPD, Chiesi has been investing since 2019 to reduce the carbon footprint of pressurized metered-dose inhalers (pMDIs).
The initiative involves developing a new platform of products known as Carbon Minimal Inhalers (CMIs), replacing the current hydrofluorocarbon-based propellant (HFA 134a) with a low-global warming potential propellant (HFA 152a).
By using the new propellant, Chiesi anticipates reducing the product's carbon footprint by up to 90% compared to the current ones, while still supporting Dry Powder Inhaler (DPI) technology to provide patients with a variety of treatment options tailored to their individual needs.
Climate Advocacy
As part of our commitment to emissions reduction, Chiesi recognizes the importance of taking a public stance to raise awareness about the climate crisis and drive positive social change and legislation. Read the latest news and activities. This commitment translates into a series of concrete actions, including:
Chiesi had already joined the Carbon Disclosure Project (CDP) and achieved an "A" rating in 2021 and 2022. In 2023, after the Climate Change questionnaire of the CDP had considerably been revised, Chiesi still proudly received an "A-" rating.
Chiesi Germany introduced WeACT Con, a fresh congress format highlighting the connections between health, environment, and sustainability.
WeACT Con brought together diverse healthcare figures, including doctors and policymakers, for a two-day event in Berlin.
With a focus on understanding how healthcare impacts climate change and vice versa,the congress aimed to explore comprehensive solutions and perspectives through collaboration and open discussion.
Supported by Chiesi, an Economist Impact report, titled Cleaner air, clearer lungs, better lives, revealed the significant impact of climate-related factors on lung health. The report explores how air quality affects health disparities and lung health, drawing from the experiences of lung disease patients in the UK, Italy, Spain, Germany, and France. It underscores the broader impact on overall well-being and advocates for comprehensive health policy solutions.
Chiesi participated in "The Climate and Us" series by BBC StoryWorks and the Global Climate and Health Alliance. This series, launched during COP 28, examines the severe impact of climate change on global human health, particularly affecting those with respiratory conditions.
In our sponsored episode, "How redesigning inhalers could reduce their environmental impact", we underscore the urgent need to minimize inhalers' environmental footprint. Lara, an asthma patient, shares her firsthand experience of the health risks posed by air pollution.





